20:35:25 EST Thu 26 Dec 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Adastra Holdings Ltd
Symbol XTRX
Shares Issued 55,970,547
Close 2024-09-25 C$ 0.09
Market Cap C$ 5,037,349
Recent Sedar Documents

Adastra interim CEO McLeod resigns

2024-09-26 17:07 ET - News Release

An anonymous director reports

ADASTRA HOLDINGS ANNOUNCES RESIGNATION OF INTERIM CEO, CFO, AND CORPORATE SECRETARY

Lachlan McLeod, interim chief executive officer, chief financial officer and corporate secretary, has resigned from his roles with Adastra Holdings Ltd.

Mr. McLeod's resignation as interim CEO, effective immediately, while he will remain in his roles as CFO and corporate secretary until Nov. 25, 2024, to ensure a smooth transition and maintain continuity as the company moves forward. The company is currently in the process of selecting and approving new candidates to fill these roles.

"It has been an honour to lead Adastra through this dynamic period of development. I am confident that the company is in a strong financial position for continued growth and success. I will work closely with the team to ensure a seamless transition and look forward to witnessing Adastra's continued achievements," said Lachlan McLeod, CEO, CFO and corporate secretary of Adastra.

About Adastra Holdings Ltd.

Adastra has become one of Canada's leaders in the supply and manufacturing of ethnobotanical and cannabis products for lawful adult use. It serves medical markets and engages in forward-looking therapeutic applications. With cannabis concentrate products sold through retailers at more than 2,000 locations across Canada, Adastra's Phyto Extractions and Endgame Extracts brands are now well established with a growing distribution presence. As a Health Canada-licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. Adastra partners with health care professionals and practitioners within the regulated environment to create products suitable for the medical cannabis market, with the ultimate aim of addressing the needs of patients.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.